Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Aegerion Pharmaceuticals, Inc.    AEGR   US00767E1029

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

06/14/2012| 06:44am US/Eastern
Recommend:
0

Among the companies with shares expected to actively trade in Thursday's session is Aegerion Pharmaceuticals Inc. (>> Aegerion Pharmaceuticals, Inc.).

Aegerion unveiled plans to offer an undisclosed number of shares of common stock, as the biopharmaceutical company looks to raise funds for activities related to the regulatory approval and commercialization of its lead product candidate. Shares were off 6.6% after hours.

 
   Watchlist: 

Codexis Inc. (>> Codexis, Inc.) said its interim chief financial officer, Brian Dowd, will resign at the end of this month in order to accept a position at a private technology company.

C.R. Bard Inc. (>> C.R. Bard, Inc.) raised its quarterly dividend by 5.3% and also authorized an additional $500 million in share repurchases, as the medical-device maker looks to increase value for its shareholders.

Korn/Ferry International's (>> Korn/Ferry International) fiscal fourth-quarter earnings fell 41% as the executive-search firm was hurt by higher costs as fee revenue rose modestly.

Moody's Investors Service downgraded commercial printer R.R. Donnelley & Sons Co. (>> R.R. Donnelley & Sons Company), saying it is concerned the company will forgo efforts to lower its debt to instead continue focusing on shareholder returns.

Spartech Corp.'s (SEH) fiscal second-quarter income rose 40% as the packaging company posted improved margins and stronger sales in its color and specialty compounding segment.

United Technologies Corp. (UTX) raised its quarterly dividend 11% as the industrial conglomerate looks to increase value for its shareholders.

-Write to Nathalie Tadena at nathalie.tadena@dowjones.com

Recommend :
0
Partner Area
React to this article
 
Latest news on AEGERION PHARMACEUTICALS,
03/29 AEGERION PHARMACEUTICALS, INC.: News and Reports On: (NASDAQ: AEGR), (NYSE: CBI..
02/21 AEGERION PHARMACEUTICALS, INC.: Tomorrow's Outlook in Today's Market - Research..
01/29DJFDA Approves Sanofi's Kynamro to Treat Rare Cholesterol Disorder
2012DJEuropean Union Rejects Isis, Genzyme Drug On Safety Concerns
2012DJFDA Panel Supports Genzyme, Isis Drug Mipomersen on 9-6 Vote
2012 FDA panel recommends Sanofi, Isis drug Kynamro for rare disorder
2012DJFDA: Genzyme, Isis Drug Mipomersen Cuts Cholesterol but Impacts Liver
2012DJFDA: Aegerion Drug Cuts Cholesterol But Has Liver Safety Risk
2012 AEGERION PHARMACEUTICALS, INC.: Insmed Appoints Will Lewis as President and Chi..
2012DJInsmed Names Will Lewis as CEO; Tim Whitten Steps Down
Advertisement
Chart
Duration : Period :
Aegerion Pharmaceuticals,  Technical Analysis Chart | AEGR | US00767E1029 | 4-Traders
Income Statement Evolution
Aegerion Pharmaceuticals,  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.